Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H6OS |
| Molecular Weight | 78.133 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[S+](C)[O-]
InChI
InChIKey=IAZDPXIOMUYVGZ-UHFFFAOYSA-N
InChI=1S/C2H6OS/c1-4(2)3/h1-2H3
| Molecular Formula | C2H6OS |
| Molecular Weight | 78.133 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dimethyl sulfoxide (DMSO) is a clear odorless liquid, inexpensively produced as a by-product of the paper industry. It is widely available in the USA as a solvent but its medical use is currently restricted by the FDA to the palliative treatment of interstitial cystitis and to certain experimental applications. In medicine, DMSO is also used as a topical analgesic, a vehicle for topical application of pharmaceuticals, as an anti-inflammatory, and an antioxidant.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | RIMSO-50 Approved UseRIMSO-50 (dimethyl sulfoxide) is indicated for the symptomatic relief of patients with interstitial cystitis. RIMSO-50 has not been approved as being safe and effective for any other indication. There is no clinical evidence of effectiveness of dimethyl sulfoxide in the treatment of bacterial infections of the urinary tract. Launch Date1978 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dimethyl sulfoxide affects the selection of splice sites. | 2001-05-18 |
|
| NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. | 2001-05 |
|
| An active site tyrosine influences the ability of the dimethyl sulfoxide reductase family of molybdopterin enzymes to reduce S-oxides. | 2001-04-20 |
|
| The water channel aquaporin-8 is mainly intracellular in rat hepatocytes, and its plasma membrane insertion is stimulated by cyclic AMP. | 2001-04-13 |
|
| Transcriptional activation of prion protein gene in growth-arrested and differentiated mouse erythroleukemia and human neoplastic cells. | 2001-04-01 |
|
| Enzymic characterization of epidermis-derived 12-lipoxygenase isoenzymes. | 2001-04-01 |
|
| Viral delivery of superoxide dismutase gene reduces cyclosporine A-induced nephrotoxicity. | 2001-04 |
|
| Exposure of neonatal female rats to p-tert-octylphenol disrupts afternoon surges of luteinizing hormone, follicle-stimulating hormone and prolactin secretion, and interferes with sexual receptive behavior in adulthood. | 2001-04 |
|
| Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription. | 2001-04 |
|
| Comparison of Unisol with Euro-Collins solution as a vehicle solution for cryoprotectants. | 2001-03-27 |
|
| Mechanical and histological characteristics of human trachea before and after cryopreservation: an opportunity for tracheal tissue banking. | 2001-03-27 |
|
| Photochemical and chemical oxidation of alpha-dimine-dithiolene metal complexes: insight into the role of the metal atom. | 2001-03-26 |
|
| Syntheses of hydrated molybdenum bronzes by reduction of MoO3 with NaBH4. | 2001-03-26 |
|
| Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. | 2001-03-23 |
|
| Determination of an optimal potential window for catalysis by E. coli dimethyl sulfoxide reductase and hypothesis on the role of Mo(V) in the reaction pathway. | 2001-03-13 |
|
| Anion recognition by thiostrepton. | 2001-03-12 |
|
| Synthesis of novel 2-azabicyclo[2.2.0]- and [2.1.1]hexanols. | 2001-03-09 |
|
| Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry. | 2001-03-01 |
|
| Alcohol enhances oxysterol-induced apoptosis in human endothelial cells by a calcium-dependent mechanism. | 2001-03 |
|
| Ran stimulates spindle assembly by altering microtubule dynamics and the balance of motor activities. | 2001-03 |
|
| Effects of styrene-7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. | 2001-03 |
|
| In-vitro growth of murine pre-antral follicles after isolation from cryopreserved ovarian tissue. | 2001-03 |
|
| New agents for the medical treatment of interstitial cystitis. | 2001-03 |
|
| Synthesis of a [18F]labeled chelidonine derivative as a possible antitumor agent. | 2001-03 |
|
| Sex steroid receptor regulation by genistein in the prepubertal rat uterus. | 2001-02-28 |
|
| Synthesis, crystal structure, spectral studies, and catechol oxidase activity of trigonal bipyramidal Cu(II) complexes derived from a tetradentate diamide bisbenzimidazole ligand. | 2001-02-26 |
|
| In vitro culture and synchronous release of Sarcocystis neurona merozoites from host cells. | 2001-02-26 |
|
| Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection. | 2001-02-24 |
|
| Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines. | 2001-02-16 |
|
| Electronic spectral studies of molybdenyl complexes. 2. MCD spectroscopy of [MoOS4]- centers. | 2001-02-12 |
|
| Systematic structural coordination chemistry of p-tert-butyltetrathiacalix[4]arene: 1. Group 1 elements and congeners. | 2001-02-12 |
|
| Crystal structure of the 100 kDa arsenite oxidase from Alcaligenes faecalis in two crystal forms at 1.64 A and 2.03 A. | 2001-02-07 |
|
| Quality control of refrigerated and cryopreserved semen using computer-assisted sperm analysis (CASA), viable staining and standardized fertilization in African catfish (Clarias gariepinus). | 2001-02-01 |
|
| Influence of N-terminal residue stereochemistry on the prolyl amide geometry and the conformation of 5-tert-butylproline type VI beta-turn mimics. | 2001-02 |
|
| Effect of iron and ascorbate on cyclosporine-induced oxidative damage of kidney mitochondria and microsomes. | 2001-02 |
|
| Albumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromer. | 2001-02 |
|
| [Ring cleavage of N-arylpyridinium salts by nucleophiles--regioselectivity and stereochemistry of the products. 1]. | 2001-02 |
|
| Comparison of cryoprotectants in the preservation of Theileria parva sporozoites using an in vitro infectivity assay. | 2001-02 |
|
| Characterization of northern pintail (Anas acuta) ejaculate and the effect of sperm preservation on fertility. | 2001-02 |
|
| Cryopreservation of equine embryos by open pulled straw, cryoloop, or conventional slow cooling methods. | 2001-01-15 |
|
| A low-power, atmospheric pressure, pulsed plasma source for molecular emission spectrometry. | 2001-01-15 |
|
| Bioaccumulation of polychlorinated biphenyls (PCBs) and dichlorodiphenylethane (DDE) methyl sulfones in tissues of seal and dolphin morbillivirus epizootic victims. | 2001-01-12 |
|
| Biohybrid microarrays--impedimetric biosensors with 3D in vitro tissues for toxicological and biomedical screening. | 2001-01-01 |
|
| [DNA repair if mucous membrane cells and lymphocytes with the comet assay]. | 2001-01 |
|
| Effect of cyclosporin A on nitric oxide production in cultured LLC-PK1 cells. | 2001-01 |
|
| [Study on the effects of DNA damage induced by cigarette smoke in male mice testicular cells using comet assay]. | 2001-01 |
|
| Oxidation of gas mixtures containing dimethyl sulfide, hydrogen sulfide, and methanethiol using a two-stage biotrickling filter. | 2001-01 |
|
| Differentiation of stromal-vascular cells isolated from canine adipose tissues in primary culture. | 2001-01 |
|
| Electron and video-light microscopy analysis of the in vitro effects of pyrantel pamoate on Giardia lamblia. | 2001-01 |
|
| Pentachlorophenol potentiates benzo[a]pyrene DNA adduct formation in adult but not infant B6C3F1 male mice. | 2001 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/dosage/dimethyl-sulfoxide.html
Usual Adult Dose for Cystitis
Interstitial cystitis:
Instill 50 mL of dimethyl sulfoxide into the bladder by catheter or Asepto syringe. Allow to remain for 15 minutes. The medication is expelled by spontaneous voiding.
Maintenance dose: Repeat every 2 weeks until maximum symptomatic relief obtained
Duration of therapy: Time intervals between therapy may be increased appropriately
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:09 GMT 2025
by
admin
on
Mon Mar 31 17:50:09 GMT 2025
|
| Record UNII |
YOW8V9698H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
M02AX03
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
CFR |
21 CFR 524.660
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
EPA PESTICIDE CODE |
177
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
108697
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
254707
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
WHO-VATC |
QG04BX13
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
WHO-VATC |
QM02AX03
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
81394
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
CFR |
21 CFR 524.981E
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
WHO-VATC |
QM02AX53
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
NCI_THESAURUS |
C45496
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
WHO-ATC |
G04BX13
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
14986
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/05/263
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
FDA ORPHAN DRUG |
104097
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
CFR |
21 CFR 524.981D
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
||
|
JECFA EVALUATION |
METHYLSULFINYLMETHANE
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
YOW8V9698H
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
3455
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | RxNorm | ||
|
906
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
m4555
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
28262
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
YOW8V9698H
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
763
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
D004121
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
DB01093
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
100000091560
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
DTXSID2021735
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
200-664-3
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
C437
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
1211006
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
80
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
DIMETHYL SULFOXIDE
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
2023
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
67-68-5
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
SUB07176MIG
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL504
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
679
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY | |||
|
122
Created by
admin on Mon Mar 31 17:50:10 GMT 2025 , Edited by admin on Mon Mar 31 17:50:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
Dimethyl sulfone is a normal oxidative metabolite product of dimethyl sulfoxide (DMSO) found in foods.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|